REGEN BIOPHARMA, INC. Convertible Notes Payable, Current
REGEN BIOPHARMA, INC. (RGBP) had Convertible Notes Payable, Current of $729.76 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-17
- 2026-06-30: Convertible Notes Payable, Current $729.76K.
- 2026-03-31: Convertible Notes Payable, Current $829.94K.
- 2025-12-31: Convertible Notes Payable, Current $968.01K.
- 2025-09-30: Convertible Notes Payable, Current $1.04M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-06-30 | $729.76K 10-Q · filed 2026-08-17 |
| 2026-03-31 | $829.94K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $968.01K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $1.04M 10-Q · filed 2026-08-17 |
| 2025-06-30 | $778.38K 10-Q · filed 2025-08-11 |
| 2024-09-30 | $499.88K 10-K · filed 2025-12-30 |
| 2018-09-30 | $350.00K 10-K · filed 2025-05-13 |
| 2016-12-22 | $40.00K 10-Q/A · filed 2017-04-28 |
| 2016-10-07 | $50.00K 10-Q/A · filed 2017-04-28 |
| 2016-09-20 | $50.00K 10-K/A · filed 2017-04-28 |
| 2016-09-08 | $50.00K 10-K/A · filed 2017-04-28 |
| 2016-08-26 | $50.00K 10-K/A · filed 2017-04-28 |
| 2016-04-06 | $50.00K 10-Q/A · filed 2017-04-28 |
| 2016-03-31 | $100.00K 10-Q/A · filed 2017-04-28 |
| 2016-03-08 | $100.00K 10-Q/A · filed 2017-04-28 |
| 2015-03-31 | $882.69K 10-K/A · filed 2017-04-28 |